18604-50-7Relevant articles and documents
Glycosidically bound aroma components from sour cherry
Schwab, Wilfried,Scheller, Gerhard,Schreier, Peter
, p. 607 - 612 (1990)
Benzyl β-d-glucoside, 2-phenylethyl β-d-glucoside, 6-hydroxy-2,6-dimethyl-octa-2(E),7-dienyl β-d-glucoside and 2-methoxy-4-(2-propenyl)phenyl β-d-glucoside were isolated from sour cherry fruit pulp by liquid chromatography. Identifications were performed,
Synthesis and antimicrobial activity of 6-triazolo-6-deoxy eugenol glucosides
De Souza, Thiago Belarmino,Raimundo, Paulo Otávio Botelho,Andrade, Saulo Fernandes,Hipólito, Taciane Maira Magalh?es,Silva, Naiara Chaves,Dias, Amanda Latercia Tranches,Ikegaki, Masaharu,Rocha, Raissa Prado,Coelho, Luiz Felipe Leomil,Veloso, Marcia Paranho,Carvalho, Diogo Teixeira,Dias, Danielle Ferreira
, p. 1 - 8 (2015)
A new series of 1,2,3-triazole eugenol glucosides were synthesized. The new compound structures were confirmed by MS, 1H NMR and 13C NMR. All of the synthesized compounds were screened for antimicrobial and cytotoxic activity. Five c
Ice recrystallization inhibitor
-
Paragraph 0106-0108, (2021/12/07)
【Challenge】Provide a small molecule ice recrystallization inhibitor with high IRI activity even in small quantities.Solution: The ice recrystallization inhibitor according to one aspect of the present invention includes a compound represented by the following chemical formula (1) as an active ingredient.【Chemical 1】 In the chemical formula (1), R1 is an alkyl group or hydrogen, R2 is an unsaturated hydrocarbon group or acyl group, and R3 is a monosaccharide or polysaccharide.【Selection Figure】Figure 2
Synthesis of eugenol-derived glucosides and evaluation of their ability in inhibiting the angiotensin converting enzyme
Alvarenga, Dalila Junqueira,Carvalho, Diogo Teixeira,Cordeiro, Cleydson Finotti,Dias, Danielle Ferreira,Matias, Laira Maria Faria,Souza, Thiago Belarmino de,Lavorato, Stefania Neiva,Pereira, Marília Gabriella Alves Goulart
supporting information, (2020/10/15)
We report here a series of glucosides which are active as inhibitors of the angiotensin converting enzyme (ACE). They are structurally related to the natural compound eugenol and exhibited significant inhibition values. Their syntheses were expeditious and we could obtain informative docking plots of them complexed to this enzyme. A glucoside derived from eugenol, carrying a carboxylic group in the aglycone, was the most active of them (with an IC50 of 0.4 mM) and showed good binding energies in docking studies with ACE. Moreover, computational prediction of toxicity risks, physicochemical properties and drug score show that the glucoside derivative of eugenol is a suitable compound for optimisation studies aimed at finding new drug candidates.
